[Federal Register Volume 88, Number 93 (Monday, May 15, 2023)]
[Notices]
[Pages 30975-30976]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-10275]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Agency for Toxic Substances and Disease Registry


National Center for State, Tribal, Local, and Territorial Public 
Health Infrastructure and Workforce, CDC and ATSDR Tribal Consultation 
Session

AGENCY: Centers for Disease Control and Prevention (CDC) and Agency for 
Toxic Substances and Disease Registry (ATSDR), Department of Health and 
Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) and the 
Agency for Toxic Substances and Disease Registry (ATSDR) announce a CDC 
and ATSDR Tribal Consultation. CDC and ATSDR will host a virtual tribal 
consultation with American Indian and Alaska Native (AI/AN) Federally 
Recognized Tribes. The proceedings will be open to the public.

DATES: The tribal consultation will be held on July 12, 2023, from 2 
p.m. to 3:30 p.m., EDT. Written tribal testimony is due by 5 p.m., EDT, 
on July 24, 2023.

ADDRESSES: Virtually through Zoom. To register, go to https://cdc.zoomgov.com/j/1610090031?pwd=V1VCa1lZR3BRVWFab1lNUEFWQUl2UT09. All 
elected tribal officials or their authorized representatives of 
federally

[[Page 30976]]

recognized AI/AN tribes are encouraged to submit written tribal 
testimony to the contact person and mailing address listed below or by 
email at [email protected].

FOR FURTHER INFORMATION CONTACT: Latonya Tripp-Dinkins, DBH, LPC, 
National Center for Injury Prevention Control, Centers for Disease 
Control and Prevention, 4770 Buford Highway, Chamblee, Georgia 30341-
3717. Telephone: (404) 956-2782; Email: [email protected].

SUPPLEMENTARY INFORMATION: This meeting is being held in accordance 
with Presidential Executive Order No. 13175 of November 6, 2000, 
Consultation and Coordination with Indian Tribal Governments, and the 
Presidential Memoranda of January 26, 2021, November 5, 2009, September 
23, 2004, and April 29, 1994, and the Centers for Disease Control and 
Prevention (CDC)/Agency for Toxic Substances and Disease Registry 
(ATSDR) Tribal Consultation Policy (https://www.cdc.gov/tribal/consultation-support/tribal-consultation/policy.html).
    Purpose: The purpose of the consultation meeting is to advance CDC 
and ATSDR support for and collaboration with American Indian and Alaska 
Native (AI/AN) tribal nations and to improve the health of AI/AN people 
by pursuing goals that include assisting in eliminating health 
disparities faced by tribal nations; ensuring that access to critical 
health and human services and public health services is maximized to 
advance or enhance the social, physical, and economic status of AI/AN 
people; and promoting health equity for all AI/AN people and 
communities. To advance these goals, CDC and ATSDR conduct government-
to-government consultations with elected tribal officials of federally 
recognized AI/AN tribes or their authorized representatives. 
Consultation is an enhanced form of communication that emphasizes 
trust, respect, and shared responsibility. It is an open and free 
exchange of information among parties that leads to mutual 
understanding and informed decision-making on behalf of the federal 
government.
    Matters to be Considered: CDC and ATSDR are hosting this meeting to 
hold consultation with federally recognized AI/AN tribes to receive 
input and guidance to inform sexual violence prevention activities and 
strategies in developing Notices of Funding Opportunity (NOFOs). CDC 
and ATSDR are seeking feedback on how the agencies can better engage 
with Indian Country through meaningful consultation and on how the 
agency can ensure that a NOFO from CDC's Rape Prevention and Education 
(RPE) program is sensitive to the needs and concerns of tribal 
communities and is as effective as possible regarding the prevention of 
sexual violence, as well as on how the agency can better support tribes 
and tribal communities moving forward regarding health inequities 
related to RPE and injury prevention. The tribal consultation meeting 
is intended to provide interested parties with an opportunity to 
discuss their public health priorities and concerns related to RPE that 
may affect tribal nations.
    The RPE program was authorized through the Violence Against Women 
Act, which was passed by Congress in 1994, and was most recently 
reauthorized in 2022. Grants awarded under this program are to be used 
for RPE programs conducted by state and territorial health departments 
and sexual assault coalitions, including tribal sexual assault 
coalitions. Additional information about the RPE program can be found 
at https://www.cdc.gov/violenceprevention/sexualviolence/rpe/index.html.
    Elected tribal officials can find guidance to assist in developing 
tribal testimony for CDC and ATSDR at https://www.cdc.gov/tribal/documents/consultation/Tribal-Testimony-Guidance.pdf. Please submit 
tribal testimony on official tribal letterhead.
    Based on the number of elected tribal officials giving testimony 
and the time available, it may be necessary to limit the time for each 
presenter. We will adjourn tribal consultation meetings early if all 
attendees who requested to provide oral testimony in advance of and 
during the consultation have delivered their comments. Agenda items are 
subject to change as priorities dictate.
    Additional information about CDC/ATSDR's Tribal Consultation Policy 
can be found at https://www.cdc.gov/tribal/consultation-support/tribal-consultation/policy.html.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-10275 Filed 5-12-23; 8:45 am]
BILLING CODE 4163-18-P